Medicare Part D plans cover popular obesity drugs if they are used for an additional medically accepted purpose as approved ...

Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with a lot of ...

Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...

In a report released today, Mathieu Chevrier from Citi maintained a Hold rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs ...